Regeneron announces formation of regeneron cell medicines with the acquisition of 2seventy bio platforms and preclinical and clinical programs

Regeneron to assume full development and commercialization rights for 2seventy bio's preclinical and clinical stage cell therapy pipeline regeneron to assume full development and commercialization rights for 2seventy bio's preclinical and clinical stage cell therapy pipeline
REGN Ratings Summary
REGN Quant Ranking